| For: | Zhang X, Liao MJ, Ren LY, Qin WY, Mu SW, She SP, Fei R, Cong X, Zhou YP, Chen DB, Chen HS. AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma. World J Gastroenterol 2025; 31(48): 113856 [PMID: 41480328 DOI: 10.3748/wjg.v31.i48.113856] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i48/113856.htm |
| Number | Citing Articles |
| 1 |
Cristian Lindner. Letter to the Editor: AADN score predicts overall and progression-free survival in triple therapy for hepatocellular carcinoma. World Journal of Gastroenterology 2026; 32(13): 116481 doi: 10.3748/wjg.v32.i13.116481
|
